The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.

@article{Henry2017TheAT,
  title={The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.},
  author={Timothy D. Henry and Carl J Pepine and Charles R. Lambert and Jay H. Traverse and Richard Schatz and Marco A. Costa and Thomas J. Povsic and R David Anderson and James T. Willerson and Steven Kesten and Emerson C. Perin},
  journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions},
  year={2017},
  volume={89 2},
  pages={169-177}
}
OBJECTIVE To assess safety and feasibility of autologous adipose-derived regenerative cells (ADRCs), for treatment of chronic ischemic cardiomyopathy patients. BACKGROUND Preclinical and early clinical trials suggest ADRCs have excellent potential for ischemic conditions. METHODS The Athena program consisted of two parallel, prospective, randomized (2:1, active: placebo), double-blind trials assessing intramyocardial (IM) ADRC delivery [40-million, n = 28 (ATHENA) and 80-million (ATHENA II… CONTINUE READING
Highly Cited
This paper has 27 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Topics

Statistics

010203020172018
Citations per Year

Citation Velocity: 14

Averaging 14 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.
Blog posts, news articles and tweet counts and IDs sourced by
Altmetric.com